Latest Insider Transactions at Actuate Therapeutics, Inc. (ACTU)
This section provides a real-time view of insider transactions for Actuate Therapeutics, Inc. (ACTU). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACTUATE THERAPEUTICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACTUATE THERAPEUTICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 14
2024
|
Todd S Thomson Director |
SELL
Open market or private sale
|
Indirect |
18,750
-1.56%
|
$150,000
$8.0 P/Share
|
|
Aug 14
2024
|
Todd S Thomson Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
28,464
+2.31%
|
$142,320
$5.27 P/Share
|
|
Aug 14
2024
|
Todd S Thomson Director |
BUY
Conversion of derivative security
|
Indirect |
2,577,312
+30.43%
|
-
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Bios Equity Cof, LP Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,999
-1.74%
|
$224,991
$9.0 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
37,951
+2.57%
|
$189,755
$5.27 P/Share
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
9,380,699
+37.41%
|
-
|
|
Aug 14
2024
|
Leslie W. Kreis > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500,000
+36.47%
|
$4,000,000
$8.0 P/Share
|